Fundraising Fox
Biomia
3 known investors
Find your way into Biomia
Sign up to see every warm intro you have to Biomia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biomia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biomia is a biotechnology company using biology, chemistry, and pharmacoengineering to develop a new generation of central nervous system (CNS) therapeutics. It focuses on drug discovery to address unmet patient needs.
Investors · 3
Amino Collectivelisted by Amino CollectiveBerlin · $216K – $1.6M
How we know: Amino Collective's portfolio page · Not right? Tell us
BlueYard Capitallisted by BlueYard CapitalBerlin · $500K – $5M
How we know: BlueYard Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Nucleus Capitallisted by Nucleus CapitalBerlin · $1M – $1.1M
How we know: Nucleus Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Biomia do?
- Biomia is a biotechnology company using biology, chemistry, and pharmacoengineering to develop a new generation of central nervous system (CNS) therapeutics. It focuses on drug discovery to address unmet patient needs.
- Who are Biomia's investors?
- Biomia's investors include Amino Collective, BlueYard Capital, Nucleus Capital.